Dexcom Inc. Stock
Price
Target price
€63.40
€63.40
1.610%
1.0
1.610%
€73.16
29.05.26 / Tradegate
WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Dexcom Inc. Stock
Dexcom Inc. gained 1.610% today.
The stock is one of the favorites of our community with 42 Buy predictions and 2 Sell predictions.
With a target price of 73 € there is a slightly positive potential of 15.14% for Dexcom Inc. compared to the current price of 63.4 €.
Our community identified positive and negative aspects for Dexcom Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Dexcom Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Dexcom Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | 1.610% | 1.929% | 28.600% | -15.150% | 10.607% | -41.285% | -16.304% |
| Baxter International | -1.360% | -2.481% | 11.291% | -39.746% | -1.086% | -58.251% | -75.976% |
| Teleflex Inc. | -0.270% | -2.895% | -2.895% | 4.434% | 8.529% | -47.783% | -66.250% |
| Dentsply Sirona Inc. | 1.970% | 1.933% | -8.865% | -37.380% | -6.528% | -73.972% | -83.672% |
Comments
DexCom (DXCM) had its "buy" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for DXCM provided by MarketBeat
DexCom (DXCM) had its price target lowered by Bank of America Corporation from $100.00 to $80.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom (DXCM) had its "underweight" rating reaffirmed by Barclays PLC. They now have a $64.00 price target on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
News
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day
DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for
Pediatrix Medical Group Q1 Earnings Call Highlights
Pediatrix Medical Group (NYSE:MD) reaffirmed its full-year 2026 adjusted EBITDA outlook after reporting what management described as a strong first quarter, supported
3 Reasons Analysts Love DexCom
While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a crucial component of a broader set of tools to address type 2 diabetes